Skip to main content

Table 6 Prescription of anticoagulants according to the CHADS2 and CHA2DS2-VASc score in the first six months after the diagnosis of atrial fibrillation (n = 1830)

From: Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study

 

CHADS2 score

 

0 (n = 285, 15.5 %)

1 (n = 654, 36 %)

≥2 (n = 891, 48.5 %)

Anticoagulants, n (%)

146 (51)

306 (47)

443 (50)

No anticoagulants, n (%)

139 (49)

348 (53)

448 (50)

 

CHA2DS2-VASc score

 

0 (n = 19, 1 %)

1 (n = 157, 9 %)

≥2 (n = 1654, 90 %)

Anticoagulants, n (%)

11 (58)

81 (52)

803 (49)

No anticoagulants, n (%)

8 (42)

76 (48)

851 (51)